节点文献

肝肾肿瘤合并布-加综合症的介入治疗

Interventional therapy in Budd-Chiari syndrome following liver cancer or renal cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张延伟苌英利薛春晓曹喜才李建华李斌徐晓冉

【Author】 ZHANG Yan-wei, CHANG Ying-li, XUE Chun-xiao, CAO Xi-cai, LI Jian-hua, LI Bin, XU Xiao-ran (Department of Radiology, the First Affiliated Hospital of Guangzhou University of TCM, Guangzhou 510405, China)

【机构】 广州中医药大学第一附属医院放射科河北石家庄钢铁股份有限公司职工医院天津医科大学总医院河北石家庄钢铁股份有限公司职工医院 广东广州510405

【摘要】 目的 探讨介入治疗在肝肾肿瘤合并布 加综合症中的应用价值。方法 肝癌 3例 ,肾癌 1例。行单纯溶栓 1例 ,PTA成形术 3例 ,PTA后再植入国产“Z”形自膨胀支架 2例。结果 术后DSA检查原侧枝循环血流明显减少。术后一周左右 ,患者的症状和体征改善明显。术后 6个月彩超随访显示支架均开通良好。结论 血管内溶栓和支架植入术是继发性BCS的首选姑息治疗方法 ,可延长患者生存时间 ,提高生存质量

【Abstract】 Objection To study the role of interventional therapy in patients with Budd-Chiari Syndrome (BSC) following liver cancer or renal cancer. Methods There were 3 liver cancers and 1 renal cancer. We administrated simple thrombolysis in 1 case, percutaneous transluminal angioplasty (PTA) in 3 cases, and PIA+self-expansion stent in 2 cases. Results Collateral circulations were obvionsly reduced after interventional therapy. The signs and symptoms of patients were significantly improved in 1 week. Colorful ultrasound examination showed all stents were still keeping open after 6 months. Conclusion The first therapy of secondary BCS following hepatic or renal tumors were thrombolysis and/or percutanous transcatheter stent placement,which can extend survival and improve the quality of patients.

  • 【文献出处】 中国医学影像技术 ,Chinese Journal of Medical Imaging Technology , 编辑部邮箱 ,2004年S1期
  • 【分类号】R735.7;R737.11
  • 【下载频次】125
节点文献中: 

本文链接的文献网络图示:

本文的引文网络